If you’re searching for a straight answer about semaglutide weight loss results, here it is: most patients lose 3 to 4% of their starting body weight in the first month, working out to roughly 6 to 10 pounds of weight loss for someone starting at 200 pounds. By the three-month mark, average results climb to around 9 to 10% of body weight. At six months, clinical trials show an average of 13 to 15%, and some patients even reach 20% or more by the end of their first year.
The STEP 1 trial, which is the largest clinical study on semaglutide 2.4 mg for weight management, followed nearly 2,000 adults over 68 weeks and documented these outcomes in detail. The numbers are real. But what they look like for your body, such as at month one, month three, and month six, all depends on certain individual factors that are worth understanding before you start your program.
This guide breaks down the expected timeline of results month by month, explains what the clinical data actually shows, and shares what InjectCo patients in Texas typically experience across their first year of treatment.
Average Weight Loss on Semaglutide at a Glance
Individual results vary. Data from the STEP 1 clinical trial (semaglutide 2.4 mg, 68 weeks).
While individual results vary, here’s a general overview of how much average weight someone on semaglutide can lose on a monthly basis:
Most patients lose 3 to 4% of their starting body weight in the first month on semaglutide. For someone starting at 200 pounds, that’s roughly 6 to 8 pounds. At 250 pounds, expect 7 to 10 pounds. This may feel modest compared to the transformation stories you see on social media, but it is clinically meaningful, and more importantly, it is just the beginning. The first month is a dose escalation phase (typically 0.25 mg weekly), so appetite suppression is only partially active. Month 2 and beyond is when the results tend to accelerate.
By the three-month mark, clinical trial data shows average weight loss of approximately 9 to 10% of starting body weight. For a 200 lb person, that is 18 to 20 pounds. At 250 lbs, roughly 22 to 25 pounds. The dose is typically higher in months 2 and 3 (moving toward 0.5 mg and then 1.0 mg weekly), which is when most patients report the strongest appetite suppression. This is when clothes fit differently and your energy improves. The STEP 1 trial specifically reported that 86% of participants lost at least 5% of their body weight by this point.
At six months, participants in the STEP 1 trial had lost an average of 13.8% of their initial body weight on semaglutide 2.4 mg, or roughly around 27 to 28 pounds for a 200 lb person. This is the phase where patients typically feel the most significant change in their body composition, energy, and overall health markers. Weight loss may slow slightly from the pace of months 2 through 4, but total results are compounding. Patients who combine semaglutide with strength training and adequate protein intake during this phase tend to preserve more lean muscle and report better results long-term.
After 12 months, patients on semaglutide 2.4 mg average 15 to 17% of their starting body weight lost when combined with lifestyle modifications. At 200 lbs, that is 30 to 34 pounds. The STEP 1 trial data at 68 weeks (approximately 16 months) showed that 32% of participants lost 20% or more of their starting weight. That represents roughly 40 pounds at a 200 lb starting point. These are not outlier results, as nearly a third of patients in a well-controlled clinical trial hit that threshold.
| Timeframe | Avg % Body Weight Lost | Approx. lbs at 200 lb Start | Approx. lbs at 250 lb Start | Source |
| Week 1-2 | Appetite reduction begins | — | — | Clinical observation |
| Week 4 (1 month) | 3-4% | 6-8 lbs | 7-10 lbs | STEP 1 trial / Fay Nutrition analysis |
| Month 3 | 9-10% | 18-20 lbs | 22-25 lbs | STEP 1 trial (68-week data) |
| Month 6 | 13-14% | 26-28 lbs | 32-35 lbs | STEP 1 trial (6-month endpoint) |
| Month 12 | 15-17% | 30-34 lbs | 37-42 lbs | STEP 1 / Mayo Clinic Diet analysis |
| Month 16 (68 weeks) | 14.9% average; 32% reached 20%+ | Up to 40+ lbs | Up to 50+ lbs | STEP 1 trial primary endpoint |
Here’s what semaglutide results show on a week-by-week basis:
Weeks 1-2: Most patients notice reduced appetite and fewer cravings within the first 7 to 14 days. The scale may not move much yet; expect 1 to 2 pounds. This is normal. The body is adjusting to the dose escalation phase at 0.25 mg weekly.
Week 4 (End of Month 1): By the end of week 4, most patients on semaglutide have lost 3 to 4% of their starting body weight. Clinical studies record an average of approximately 3.8% at the 4-week mark. For a 200 lb person, that is 7 to 8 pounds.
Weeks 5-8: Weight loss accelerates as the dose increases toward 0.5 mg weekly. This is the phase where many patients first notice clothing fit changes and report stronger appetite suppression. Expect 1 to 2 pounds per week on average.
Weeks 9-16: By week 16, patients on semaglutide moving toward maintenance doses of 1.0 mg or higher have often lost 15 to 20 pounds or more from their starting weight, depending on adherence, diet, and starting point. Total progress at this stage typically reflects 8 to 12% of starting body weight.
Before and after results on semaglutide look different for every patient, but there are specific weight loss patterns worth knowing.
What changes beyond the scale is that patients consistently report reduced hunger throughout the day, fewer late-night cravings, improved sleep quality, and reduced joint pressure. Many describe the first 30 days as ‘the quietest my hunger has ever been.’
If you’re considering semaglutide and want to see results from Texas patients specifically, our team at InjectCo provides free consultations at our Fort Worth and Plano locations, and across all nine Texas clinics. Book yours at injectco.com/services/compounded-semaglutide-online/.
Here are the different factors affecting how much weight patients lose on semaglutide:
Patients with higher starting weights typically lose more absolute pounds, even if the percentage is similar. Someone starting at 300 lbs and losing 10% loses 30 pounds. Someone at 180 lbs loses 18 pounds. The math favors those with more to lose, which is also clinically appropriate.
The standard maintenance dose for weight loss is 2.4 mg weekly. Patients who titrate too slowly or stay at sub-therapeutic doses for too long see slower results. Work with your provider to reach the appropriate dose for your weight loss goals.
Semaglutide reduces appetite, which can unintentionally cut protein intake. This accelerates muscle loss. Patients who prioritize 1.2 to 1.6 grams of protein per kilogram of goal body weight and lift weights 3 to 4 times weekly consistently outperform those who rely on the medication alone.
Patients with insulin resistance, hypothyroidism, or PCOS may see slower initial results. This does not mean semaglutide is not working; it only means the underlying condition needs concurrent management. Results typically catch up as the metabolic issue is addressed.
Missing weekly injections or skipping doses reduces effectiveness and can increase side effects when the medication resumes. Set a consistent injection day, keep supplies accessible, and treat the injection schedule like a weekly commitment.
Yes, losing 20 pounds on semaglutide is a realistic goal for most patients. At a typical pace of 3 to 4% body weight lost in month one and 9 to 10% by month three, a 200 lb patient reaches the 20-pound threshold somewhere between months 2 and 4.
The faster you reach your therapeutic dose and the more consistent you are with weekly injections and protein intake, the more quickly you approach that milestone. Some patients hit 20 pounds before the 3-month mark, while others take 4 to 5 months. Neither timeline represents failure; both represent meaningful, sustainable progress.
The STEP 1 trial data shows 32% of participants lost 20% or more of their body weight over 68 weeks. For a 200 lb patient, that’s 40 pounds. Twenty pounds is a realistic early milestone for most patients.
Here are the most common side effects of semaglutide and how to better manage them:
The most common early side effect, typically occurring in the first 4 to 8 weeks during dose escalation. Managed by eating smaller, more frequent meals, avoiding high-fat foods, and not lying down immediately after eating. Nausea usually decreases significantly as the body adjusts to each new dose.
Slowed gastric emptying reduces bowel movement frequency for some patients. Increase fiber intake gradually, drink 64 to 80 ounces of water daily, and maintain regular physical activity. A fiber supplement may help if dietary adjustments are not enough.
Some patients experience low energy in the first few weeks, particularly during dose increases. While this typically resolves on its own, adequate protein intake, hydration, and consistent sleep schedules help patients better manage this period.
Mild redness, itching, or swelling at the injection site can occur. Rotate sites weekly, let the medication reach room temperature before injecting, and apply ice after if needed. Persistent or worsening reactions should be reported to your provider.
Medical consensus has shifted firmly toward treating obesity as a chronic condition, which means semaglutide is increasingly viewed as a long-term medication rather than a short-term course. Most providers recommend remaining on semaglutide for at least 12 to 18 months during active weight loss, then transitioning to a maintenance dose rather than stopping entirely.
The STEP 1 extension study is unambiguous on what happens when patients stop: participants who discontinued semaglutide regained approximately two-thirds of their lost weight within one year. This isn’t a failure of willpower or the medication; it only reflects the biology of the GLP-1 system. When the medication is removed, appetite regulation returns to its previous baseline.
Some patients reduce to a lower maintenance dose (1.0 to 1.7 mg weekly) after reaching their goal weight, while others continue at the full 2.4 mg dose. Your provider will recommend the right approach based on your results, tolerability, and weight maintenance goals.
At InjectCo, our nurse-led medical team monitors your progress monthly and adjusts your physician-supervised semaglutide program as your body changes.
Based on the clinical evidence: most patients lose 3 to 4% of body weight in their first month, 10% by month three, and 15% or more over their first year of treatment when combining semaglutide with lifestyle changes. Some even reach 20% or more. Individual results depend on starting weight, dose, consistency, and daily habits.
Semaglutide is appropriate for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related health condition. It requires a medical evaluation and prescription, and it is not appropriate for patients with a personal or family history of medullary thyroid carcinoma, certain types of pancreatitis, or specific other contraindications.
At InjectCo, our medical team provides comprehensive, physician-supervised semaglutide programs including medical screening, prescription, and monthly progress monitoring across all nine Texas locations. Our Fort Worth and Plano clinics offer in-person consultations. Book a free virtual consultation at injectco.com/services/compounded-semaglutide-online/.
Most patients lose 3 to 4% of their starting body weight in the first month on semaglutide. For a 200 lb person, that is approximately 6 to 8 pounds. At 250 lbs, expect 7 to 10 pounds. The first month is a dose escalation phase, which means appetite suppression is only partially active. Results accelerate significantly in months 2 and 3 as the dose increases. Patients who experience modest first-month results are not non-responders; they are simply in the early ramp-up phase.
Clinical data shows an average of 9 to 10% of starting body weight lost by the three-month mark on semaglutide. For a 200 lb person, that is 18 to 20 pounds. For someone starting at 250 lbs, roughly 22 to 25 pounds. The STEP 1 trial recorded that 86% of participants had lost at least 5% of their body weight by this point, and over 50% had lost 10% or more. The 3-month mark is when most patients report the most noticeable physical changes.
The average weight loss on semaglutide is approximately 2 to 4 pounds per month in the first two months, accelerating to 3 to 6 pounds per month during the peak effectiveness period of months 3 through 8. Over 68 weeks, the overall average is 14.9% of starting body weight. Monthly results vary based on starting weight, dose, adherence, and lifestyle factors. Patients who combine semaglutide with lifestyle changes such as protein-focused nutrition and strength training typically land at the higher end of these ranges.
Semaglutide begins working within the first week, and most patients notice reduced appetite and fewer cravings by days 7 to 14. However, noticeable scale changes typically begin around the 3 to 4 week mark. The medication takes 4 to 5 weeks to reach steady-state blood levels, which is why the dose titration schedule starts low and increases gradually. Do not judge results by the first two weeks alone. The full effectiveness of semaglutide becomes apparent at 8 to 12 weeks.
On average, patients lose 14.9% of their starting body weight over 68 weeks on semaglutide 2.4 mg weekly, according to the STEP 1 trial. Here’s an honest breakdown: 86% of participants lost at least 5%, 69% of patients lost 10% or more, 50% of individuals lost 15% or more, and 32% of users lost 20% or more. The practical ceiling for most patients in the first year falls between 15 and 20% of body weight. Some patients, particularly those who combine the medication with intensive lifestyle changes, exceed 20%.
At six months, the STEP 1 trial recorded an average weight loss of 13.8% of initial body weight on semaglutide 2.4 mg. That is approximately 27 to 28 pounds for someone starting at 200 lbs. At a 250 lb starting weight, expect 34 to 35 pounds. This is the phase when most patients feel the most significant change in body composition, energy levels, and health markers. Weight loss may slow slightly from the pace of months 2 through 4, but cumulative results continue to compound.
Compounded semaglutide contains the same active ingredient as brand-name GLP-1 medications and works through the same mechanism: activating GLP-1 receptors to reduce appetite and slow gastric emptying. The key variables are compounding pharmacy quality, dosing accuracy, and proper storage.
At InjectCo, we source compounded semaglutide from licensed compounding pharmacies and provide full medical oversight throughout our physician-supervised program.
Yes. Losing 20 pounds on semaglutide is a realistic outcome for most patients. At a 200 lb starting weight, 20 pounds represents 10% of body weight, which clinical data shows over 69% of semaglutide users achieve. Patients typically reach the 20-pound milestone between months 2 and 4, depending on starting weight, dose, and adherence. Patients starting at higher weights often hit 20 pounds earlier. The STEP 1 trial shows 32% of participants ultimately lost 20% of their body weight (40 lbs at 200 lbs), indicating 20 lbs is well within reach for the majority of patients.
Most patients do regain weight after stopping semaglutide if they do not maintain the lifestyle habits developed during treatment. The STEP 1 extension study showed participants regained approximately two-thirds of their lost weight within one year of discontinuing the medication. This reflects the biology of GLP-1 regulation and is not necessarily a failure of the medication.
Patients who establish sustainable eating patterns, regular exercise, adequate sleep, and stress management maintain better results. Many providers recommend transitioning to a lower maintenance dose rather than stopping entirely to avoid this rebound or weight gain.
For a 200 lb person, the average weight loss on semaglutide at 3 months is approximately 18 to 20 pounds, based on the 9 to 10% average body weight reduction seen in clinical trials at the 3-month mark. This assumes standard titration (0.25 mg in month 1, moving to 0.5 mg in month 2, then 1.0 mg by month 3) and consistent weekly injections. Patients who reach higher doses sooner or who combine semaglutide with structured nutrition programs may see results at the higher end or beyond this range.
days day
hours hour
minutes minute
seconds second
